APPLYING NEXT GENERATION SEQUENCING (NGS) TO FIND GENE MUTATIONS IN CHILDREN WITH NEPHROTIC SYNDROME: CASE REPORTS

Diệp Đường Thị Hồng, Vũ Văn Lộc, Uyên Trần Nguyễn Như

Main Article Content

Abstract

Objective: To develop a whole exon next-generation sequencing (Illumina - WES) procedure to screen for gene mutations in pediatric patients diagnosed with NS and confirm the results by Sanger sequencing. Methods: Blood samples of 4 pediatric patients diagnosed with NS by a doctor based on clinical manifestations, blood and urine tests. Protocol - developing study. Including: DNA extraction from blood samples using the Qiagen (USA) kit, capture hybridized DNA fragments of target genes and construct a sequencing library using the New England Biolabs (USA) kit, sequence using the Illumina (USA) next-generation sequencing system, and confirm the results by Sanger sequencing. Result: A homozygous variant NM_014625.2:c.799G>T (p.Asp267Tyr) in the NPHS2 gene of 2 pediatric patients were detected, it is consistent with the initial diagnosis of corticosteroid-resistant NS by the doctor. In additon, a heterozygous variant c.2858 G>T (Gly953Val) in the COL4A5 gene and heterozygous variant c.3255 G>A (Met1085Ile) in the COL4A3 gene were detected in a pediatric patient, initially diagnosed with focal segmental glomerulosclerosis (FSGS). Futhermore a heterozygous variant c.2630 G>A in the COL4A4 gene of a patient who is being treated and monitored by the doctor for congenital NS. Conclusion: The NGS sequencing workflow for detecting mutations in target genes from blood samples of patients with nephrotic syndrome (NS)  has been successfully established in our laboratory. The sequencing results were analyzed by insilico tools such as Polyphen and SIFT software to predict the function of gene mutations. Alport syndrome can be missed diagnosis.

Article Details

References

1. Tarshish PE, Tobin JN, Bernstein J, Edelmann Jr CM. Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. Journal of the American Society of Nephrology. 1997 May 1;8(5):769-76.
2. Ehrich JH, Geerlings C, Zivicnjak M, et al. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated. Nephrol Dial Transplant 2007; 22:2183.
3. Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K, Hangan D, Ozaltin F, Zenker M, Hildebrandt F, Arbeitsgemeinschaft fur Paediatrische Nephrologie Study Group. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics. 2007 Apr 1;119(4):e907-19.
4. Lipska-Ziętkiewicz BS, Ozaltin F, Hölttä T, et al. Genetic aspects of congenital nephrotic syndrome: a consensus statement from the ERKNet-ESPN inherited glomerulopathy working group. Eur J Hum Genet 2020; 28:1368.
5. Lovric S, Ashraf S, Tan W, Hildebrandt F. Genetic testing in steroid-resistant nephrotic syndrome: when and how? Nephrol Dial Transplant 2016; 31:1802.
6. Trautmann A, Boyer O, Hodson E, et al. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 2023; 38:877.
7. Sadowski CE, Lovric S, Ashraf S, et al. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol 2015; 26:1279.